373 related articles for article (PubMed ID: 33618984)
1. Endocrine disrupting chemicals and bone.
Turan S
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101495. PubMed ID: 33618984
[TBL] [Abstract][Full Text] [Related]
2. Endocrine Disruptor-Induced Bone Damage Due to Hormone Dysregulation: A Review.
Iwobi N; Sparks NR
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175969
[TBL] [Abstract][Full Text] [Related]
3. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review.
Sirohi D; Al Ramadhani R; Knibbs LD
Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210
[TBL] [Abstract][Full Text] [Related]
4. Endocrine-Disrupting Chemicals: Introduction to the Theme.
Lisco G; Giagulli VA; Iovino M; Guastamacchia E; Pergola G; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):677-685. PubMed ID: 33847259
[TBL] [Abstract][Full Text] [Related]
5. Bone Disruption and Environmental Pollutants.
Giannattasio R; Lisco G; Giagulli VA; Settembrini S; De Pergola G; Guastamacchia E; Lombardi G; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):704-715. PubMed ID: 33461478
[TBL] [Abstract][Full Text] [Related]
6. Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children.
O'Shaughnessy KL; Fischer F; Zenclussen AC
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101568. PubMed ID: 34565681
[TBL] [Abstract][Full Text] [Related]
7. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
8. The effect of endocrine-disrupting chemicals on placental development.
Yan Y; Guo F; Liu K; Ding R; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
[TBL] [Abstract][Full Text] [Related]
9. Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?
Predieri B; Iughetti L; Bernasconi S; Street ME
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233201
[TBL] [Abstract][Full Text] [Related]
10. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
[TBL] [Abstract][Full Text] [Related]
11. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.
Winz C; Zong WX; Suh N
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23506. PubMed ID: 37598318
[TBL] [Abstract][Full Text] [Related]
12. A review of the endocrine disrupting effects of micro and nano plastic and their associated chemicals in mammals.
Ullah S; Ahmad S; Guo X; Ullah S; Ullah S; Nabi G; Wanghe K
Front Endocrinol (Lausanne); 2022; 13():1084236. PubMed ID: 36726457
[TBL] [Abstract][Full Text] [Related]
13. Endocrine-Disrupting Chemicals and Disease Endpoints.
Ahn C; Jeung EB
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
[TBL] [Abstract][Full Text] [Related]
14. A new identity of microcystins: Environmental endocrine disruptors? An evidence-based review.
Zhang S; Liu H; Du X; Chen X; Petlulu P; Tian Z; Shi L; Zhang B; Yuan S; Guo X; Wang Y; Guo H; Zhang H
Sci Total Environ; 2022 Dec; 851(Pt 2):158262. PubMed ID: 36029820
[TBL] [Abstract][Full Text] [Related]
15. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
16. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disrupting chemicals and disease susceptibility.
Schug TT; Janesick A; Blumberg B; Heindel JJ
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
[TBL] [Abstract][Full Text] [Related]
18. Endocrine-disrupting chemicals and skin manifestations.
Ju Q; Zouboulis CC
Rev Endocr Metab Disord; 2016 Sep; 17(3):449-457. PubMed ID: 27363826
[TBL] [Abstract][Full Text] [Related]
19. Endocrine Disrupting Chemicals, Hormone Receptors, and Acne Vulgaris: A Connecting Hypothesis.
Rao A; Douglas SC; Hall JM
Cells; 2021 Jun; 10(6):. PubMed ID: 34207527
[TBL] [Abstract][Full Text] [Related]
20. Bone and bone marrow disruption by endocrine-active substances.
Agas D; Lacava G; Sabbieti MG
J Cell Physiol; 2018 Jan; 234(1):192-213. PubMed ID: 29953590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
